Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Catalyst

A bitter battle over the ‘orphan drug’ program leaves patients’ pocketbooks at risk

A prescription drug that helps Lore Wilkinson walk and talk despite a rare muscle disease cost her so little for more than a decade that she didn’t even use her insurance to pay for it. But now, her Medicare insurance is shelling out about $40,000 for a one-month supply of…

Tribune News Service

51% of women experience racism at work as employers experience 'not here' syndrome

A new study shows how various aspects of women's identities subject them to racism at work.

Fortune

Women report stunning levels of discrimination

A survey's stark results comes as some companies are pulling back on certain diversity and inclusion efforts.

Axios

From analysis to the latest developments in health,
read the most diverse news in one place.

'We destroy lives': Pearson urges schools to use explicit instruction over inquiry

The scholar and activist has praised the Canberra Goulburn archdiocese's Catalyst program as a beacon for the country.

The Canberra Times

January sales: London homes with hefty price cuts or cash incentives for buyers

This year’s January sales offer some substantial savings for home buyers, with asking prices slashed and major sweeteners on offer

Evening Standard

Entrepreneurship programme offers £10,000 funding for raft of start ups

The Co-Founders programme is designed to help validate and then commercialise business ideas

Birmingham Post

These employees pay the highest ‘emotional tax’ at work

New research from Catalyst finds marginalized employees constantly feel “on guard” at work and it's detrimental to retaining racially diverse employees.

Fortune

Read news from The Economist, FT, and more,
with one subscription

‘Apex isn’t for you’ if you have an issue with Catalyst, Apex Legends’ first trans woman

Apex Legends has always aimed to be inclusive, and with the game's first trans woman coming soon, the game's lead writer makes a statement.

USA Today Sports Media Group

One-third of workers want to quit over how their company handled the abortion ruling

The great resignation may see another, more conscience-driven wave as US workers debate exiting companies whose responses to the US Supreme Court’s decision to overturn Roe v. Wade left something to be desired.

Tribune News Service

Catalyst matches Northern Ireland high-growth companies with visiting VCs

The Inbound Investor saw 55 entrepreneurs pitch in front of investors from across the UK and Ireland

Birmingham Post

Residents fear building collapse due to cracks 'so big they can see through them'

Huge cracks have started appearing in the building, which contains 36 flats, over the past few months - with one so big that a tenant can see from his bedroom through to the kitchen

Daily Mirror

Why these ACT students and teachers headed to class during the holidays

Experts from WA were on hand to show explicit teaching isn't all "drill and kill".

The Canberra Times

How dancing can help slow — and potentially reverse — the ageing process

For most of us, dancing is a fun way to unwind, or something we do after a few too many drinks on a Saturday night. But what if dancing can actually help to slow — or in some cases even reverse — the ageing process?

ABC News

High speed answers for high risk events

A niche piece of technology used by scientists and researchers to rapidly work out the dangers and effects of natural hazard events is winning acclaim and international interest

Newsroom.co.nz

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - AU

Job agency refers welfare recipients to online course asking basic questions about computers

Employability course created by company related to job agency labelled a ‘waste of time, waste of resources’ by one jobseeker

Benzinga

The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner

Here's a roundup of top developments in the biotech space over the last 24 hours:

The Canberra Times

The education revolution taking place in Canberra schools

Catholic educators are moving towards explicit, direct instruction over inquiry-based learning - and the early results are very promising.

Birmingham Post

Newcastle innovation centre The Catalyst at full capacity after two years

The centre is part of the Newcastle Helix development, which aims to bring together firms in a number of leading edge scientific sectors

Get all your
news in one place.

100’s of premium titles.
One news app.

Newsroom.co.nz

Crunch time for calculating farming emissions

Agricultural businesses need not worry about their initial emissions result being held against them, according to industry leaders

Birmingham Post

Co-Founders programme awards 10 startups £10,000 each to develop product ideas

The teams will now go on to Co-Founders+ where they'll be given mentors and specialists to accelerate their ideas

Birmingham Post

Northern Ireland science hub Catalyst announces finalists for INVENT start-up competition

The winner of the influential competition will take home £25,000

Newsroom.co.nz

Open-source history: How NZ led a global e-learning revolution

Nearly 20 years ago, Aotearoa – and Catalyst – were at the forefront of an e-learning revolution. Now, with the creation of Te Pūkenga, there's a chance to do it again, writes Don Christie

Benzinga

Catalyst Biosciences Stock More Than Doubles After Assets Sale To Vertex

Catalyst Biosciences Inc (NASDAQ:CBIO) has agreed to sell its portfolio of protease medicines that regulate complement to Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for $60 million. "This sale is part of the ongoing strategic process that we announced in February to explore alternatives and create value for shareholders. We have significantly reduced our cash burn and continue…

Benzinga

Why Catalyst Biosciences Shares Are Skyrocketing Today

Catalyst Biosciences Inc (NASDAQ: CBIO) shares are trading higher by 180.26% at $1.06 after the company announced it sold its complement portfolio for $60 million.

Birmingham Post

North East firms' role in £5.6m ageing programme helping people live longer and happier lives

A scheme spearheaded by Newcastle's National Centre for Ageing and the North of Tyne Combined Authority launches to businesses on May 25

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Canberra

Vertex Pharmaceuticals Incorporated

64 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.